Afinitor Alternatives Compared
Afinitor | Kisqali | Piqray |
|
---|
Afinitor (everolimus) | Kisqali (ribociclib) | Piqray (alpelisib) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Afinitor (everolimus) is a targeted medicine that may be used to treat various cancers and TSC-associated conditions. It reduces the blood supply to the cancers which slows down their growth and... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. Kisqali may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer, Breast Cancer - Male. Piqray may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Afinitor (everolimus) | More about Kisqali (ribociclib) | More about Piqray (alpelisib) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Afinitor has an average rating of 5.4 out of 10 from a total of 20 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 42% reported a negative effect. |
Kisqali has an average rating of 8.5 out of 10 from a total of 25 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 4% reported a negative effect. |
Piqray has an average rating of 6.3 out of 10 from a total of 3 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Afinitor side effects in more detail. |
See also: Kisqali side effects in more detail. |
See also: Piqray side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Afinitor prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Piqray prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other everolimus brands include: Afinitor Disperz, Zortress |
N/A |
Other alpelisib brands include: Vijoice | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
35 hours |
54.7 hours |
9 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 516 drugs are known to interact with Afinitor:
|
A total of 708 drugs are known to interact with Kisqali:
|
A total of 313 drugs are known to interact with Piqray:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
March 30, 2009 |
March 13, 2017 |
May 24, 2019 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.